Anteris Technologies hails FDA early feasibility study approval for DurAVR™
News Direct
Dec 06, 2022
–News Direct–
Contact Details
Proactive Investors
Jonathan Jackson
+61 413 713 744
Jonathan@proactiveinvestors.com
View original content to download multimedia: https://newsdirect.com/news/anteris-technologies-hails-fda-early-feasibility-study-approval-for-duravr-684411792